GlassScriptPhysician profile
Scott A Vota
NPI 1497782320
$8,651.45
in general payments reported to CMS, 2019-2025
46 companies · $340 in 2025
The $340 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $542 · 2020: $3,896 · 2021: $1,031 · 2022: $1,106 · 2023: $999 · 2024: $738 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,877 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,876.98 |
| Education | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tanabe Pharma America, INC. | $2,233.27 | 2019-2022 | |
| Biogen, INC. | $1,316.41 | 2019-2025 | Leqembi |
| Abbvie INC. | $732.25 | 2020-2025 | Ubrelvy, Botox, Vraylar |
| Alexion Pharmaceuticals, INC. | $546.63 | 2019-2025 | Ultomiris |
| Novartis Pharmaceuticals Corporation | $391.78 | 2019-2021 | |
| Sk Life Science, INC. | $288.31 | 2022-2024 | Xcopri |
| Amgen INC. | $240.74 | 2019-2021 | |
| Lundbeck LLC | $229.89 | 2024-2025 | Vyepti |
| Kyowa Kirin, INC. | $182.82 | 2022-2023 | Nourianz |
| Neurelis, INC. | $179.36 | 2022-2024 | Valtoco |
| Ucb, INC. | $177.82 | 2020-2024 | Briviact |
| Emd Serono, INC. | $177.05 | 2019-2023 | Mavenclad |
| Teva Pharmaceuticals USA, INC. | $157.81 | 2019-2022 | |
| Greenwich Biosciences, INC. | $156.00 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $138.30 | 2021 |
Show all 44 companies
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Vota listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.